EIF6 and metabolic dysfunction-associated steatotic liver disease: Thus, the targeting of eIF6-driven translation hinders NAFLD-HCC progression, interfering with FAS and lipid accumulation and preserving mitochondrial bioenergetic activity and FAO [91].